Invention Grant
- Patent Title: Methods and compositions for treating neuropathic pain
-
Application No.: US15324118Application Date: 2015-07-08
-
Publication No.: US09932594B2Publication Date: 2018-04-03
- Inventor: Patrick Carroll , Alexandre Pattyn , Stephanie Venteo
- Applicant: INSERM (Institut National de la Sante et de la Recherche Medicale) , Universite de Montpellier
- Applicant Address: FR Paris FR Montpellier
- Assignee: INSERM (Institut National de la Sante et de la Recherche Medicale),Universite de Montpellier
- Current Assignee: INSERM (Institut National de la Sante et de la Recherche Medicale),Universite de Montpellier
- Current Assignee Address: FR Paris FR Montpellier
- Agency: Whitham, Curtis & Cook, P.C.
- Priority: EP14306114.1 20140709
- International Application: PCT/EP2015/065545 WO 20150708
- International Announcement: WO2016/005422 WO 20160114
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C12N15/11 ; C07H21/02 ; C07H21/04 ; C12N15/113
Abstract:
The present invention relates to an inhibitor of FXYD2 gene expression for use in a method for treating neuropathic pain in a patient in need thereof. The invention also relates to a pharmaceutical composition comprising an inhibitor of FXYD2 gene expression, wherein said pharmaceutical composition is formulated for a direct administration into the peripheral nervous system (PNS) of a patient (e.g., formulated for intrathecal administration).
Public/Granted literature
- US20170183662A1 Methods and Compositions for Treating Neuropathic Pain Public/Granted day:2017-06-29
Information query
